Prolonged Recurrence-Free Survival by Autologous Rectronectin-Activated Killer (RAK) Cells in Resected High-Risk Hepatocellular Carcinoma: an Experimental Single-Arm Phase II Trial (pilot Study).
International journal of surgery (London, England)（2025）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要